Jump to content

Nuvalent’s ROS1 trial; A Study of NVL-520 in Patients Harboring ROS1 Rearrangement


Recommended Posts

UPDATE- Nuvalent’s ROS1 trial; A Study of NVL-520 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1), is now posted on Clinicaltrials.gov. SCRI (Dr. Johnson) and UCI (Dr. Ou) are both open to enrolling patients and the team is working hard to activate additional US sites this year. https://clinicaltrials.gov/ct2/show/NCT05118789?term=nuvalent&draw=2&rank=1

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.